These low-priced stocks are flashing overbought signals
Seeking Alpha News (Fri, 3-Jul 8:05 AM ET)
Globe Newswire (Tue, 2-Jun 7:30 AM ET)
Aveanna Healthcare Announces Successful Debt Repricing
Globe Newswire (Thu, 28-May 8:00 AM ET)
Aveanna Healthcare Raises 2026 Outlook as Q1 Adjusted EBITDA Climbs 25.2%
Market Chameleon (Thu, 14-May 3:32 AM ET)
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
Globe Newswire (Thu, 14-May 7:00 AM ET)
Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
Globe Newswire (Tue, 12-May 7:30 AM ET)
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
Globe Newswire (Tue, 28-Apr 7:30 AM ET)
Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
Globe Newswire (Thu, 23-Apr 6:30 AM ET)
Aveanna's 2025 Results Mark Largest Annual Profit Yet as EBITDA Surges 75% and Guidance Holds Steady
Market Chameleon (Fri, 20-Mar 6:07 AM ET)
Aveanna Healthcare Lifts 2025 Outlook Amidst Surging Revenue and Margin Expansion
Market Chameleon (Thu, 6-Nov 3:33 AM ET)
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Aveanna Healthcare Hldgs trades on the NASDAQ stock market under the symbol AVAH.
As of July 8, 2026, AVAH stock price climbed to $9.68 with 550,022 million shares trading.
AVAH has a beta of 1.55, meaning it tends to be more sensitive to market movements. AVAH has a correlation of 0.08 to the broad based SPY ETF.
AVAH has a market cap of $2.11 billion. This is considered a Mid Cap stock.
Last quarter Aveanna Healthcare Hldgs reported $648 million in Revenue and $.18 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.05.
In the last 3 years, AVAH traded as high as $10.32 and as low as $.85.
The top ETF exchange traded funds that AVAH belongs to (by Net Assets): VTI, IWM, FESM, VXF, IWO.
AVAH has outperformed the market in the last year with a price return of +125.1% while the SPY ETF gained +20.7%. AVAH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +50.1% and +18.0%, respectively, while the SPY returned +12.8% and +1.1%, respectively.
AVAH support price is $9.34 and resistance is $9.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVAH shares will trade within this expected range on the day.
